GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Invion Ltd (ASX:IVX) » Definitions » Inventories, Other

Invion (ASX:IVX) Inventories, Other : A$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Invion Inventories, Other?

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Invion's other inventories for the quarter that ended in Dec. 2024 was A$0.00 Mil.


Invion Inventories, Other Historical Data

The historical data trend for Invion's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Invion Inventories, Other Chart

Invion Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Invion Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Invion Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.


Invion Business Description

Traded in Other Exchanges
Address
692 High Street, East Kew, VIC, AUS, 3102
Invion Ltd is an Australian clinical-stage pharmaceutical drug development company. It is engaged in the development of PhotoDynamic Therapy (PDT) for cancer treatments called Photosoft, for the treatment of a range of cancers and infectious diseases. The company produces topical and intravenous products suitable for use in skin cancer and solid tumors, such as ovarian, prostate, and lung cancer. Invion has developed a portfolio of patent protected compounds. Its drug candidate is INV043, a novel photosensitiser which has the potential to work as a therapy and a diagnostic tool.

Invion Headlines

No Headlines